1. Home
  2. DCTH vs RGR Comparison

DCTH vs RGR Comparison

Compare DCTH & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$16.31

Market Cap

578.4M

Sector

Health Care

ML Signal

HOLD

Logo Sturm Ruger & Company Inc.

RGR

Sturm Ruger & Company Inc.

HOLD

Current Price

$38.66

Market Cap

601.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
RGR
Founded
1988
1949
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Ordnance And Accessories
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
578.4M
601.9M
IPO Year
2015
1994

Fundamental Metrics

Financial Performance
Metric
DCTH
RGR
Price
$16.31
$38.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$22.00
$43.00
AVG Volume (30 Days)
686.8K
98.5K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
1.07%
EPS Growth
107.53
N/A
EPS
0.04
0.44
Revenue
N/A
$546,057,000.00
Revenue This Year
$24.54
$2.38
Revenue Next Year
$33.15
N/A
P/E Ratio
$412.00
$84.39
Revenue Growth
N/A
1.94
52 Week Low
$8.12
$28.33
52 Week High
$17.42
$48.21

Technical Indicators

Market Signals
Indicator
DCTH
RGR
Relative Strength Index (RSI) 59.15 42.61
Support Level $9.98 $36.73
Resistance Level $17.42 $38.99
Average True Range (ATR) 0.45 0.86
MACD -0.19 -0.04
Stochastic Oscillator 30.65 5.91

Price Performance

Historical Comparison
DCTH
RGR

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

Share on Social Networks: